文献速递类风湿关节炎

生物制剂改善病情抗风湿药对类风湿关节炎患者外周免疫细胞表型的差异化影响

Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

该研究通过八色流式细胞术检测108例传统DMARDs无应答的RA患者及33名健康对照的外周免疫细胞表型,并评估24周bDMARDs治疗的影响。活动性RA患者Tfh细胞、IgD-CD27-双阴性B细胞和pDCs比例高于健康对照,不同bDMARDs对免疫细胞表型产生不同改变,Tfh细胞比例是阿巴西普治疗反应的独立显著预测因子。

要点

  • 活动性RA患者Tfh细胞、双阴性B细胞和pDCs比例高于健康对照。
  • TNF抑制剂降低pDCs比例,托珠单抗降低双阴性B细胞并增加naïve和活化Treg。
  • 阿巴西普显著降低活化Tfh比例,Tfh细胞比例可独立预测阿巴西普治疗反应。

核心结论

  • 分子靶向治疗诱导不同免疫细胞表型的不同变化,Tfh细胞可能是阿巴西普的潜在靶点,免疫表型分析或有助于预测bDMARDs治疗反应。

研究设计与样本

  • 研究纳入108例对传统DMARDs无应答的RA患者和33名健康对照,采用八色流式细胞术检测外周免疫细胞表型,并评估24周bDMARDs治疗的影响。

主要发现

  • 活动性RA患者Tfh细胞、IgD-CD27-双阴性B细胞和pDCs比例高于健康对照。
  • 记忆T细胞、Th17和Tfh细胞百分比与自身抗体滴度相关,浆母细胞百分比与疾病活动度评分相关。
  • TNF抑制剂降低pDCs比例,托珠单抗降低双阴性B细胞比例但增加naïve和活化Treg细胞。
  • 阿巴西普治疗显著降低活化Tfh比例,轻度降低Th17和Treg细胞。
  • Tfh细胞比例是阿巴西普治疗反应的独立显著预测因子。

临床怎么用

  • 不同bDMARDs对RA患者外周免疫细胞表型的影响存在差异,Tfh细胞比例或可用于预测阿巴西普治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess the therapeutic effects of biological DMARDs (bDMARDs) on the diversity of immune cell phenotypes in peripheral blood of patients with RA. METHODS: Peripheral immune cell phenotypes were determined in 108 RA patients who were non-responsive to conventional DMARDs and 33 healthy control subjects by eight-colour flow cytometry. We also examined the correlation between the phenotypes and clinical findings and assessed the effects of 24-week treatment with bDMARDs. RESULTS: The proportions of T follicular helper (Tfh) cells, IgD- CD27- double negative B cells and plasmacytoid dendritic cells (pDCs) were higher in patients with active RA than in healthy control. The percentages of memory T cells, Th17 and Tfh cells correlated with autoantibody titres, whereas that of plasmablasts correlated with disease activity scores. Treatment with TNF inhibitors reduced the proportion of pDCs, while tocilizumab reduced the proportion of double-negative B cells but increased naïve and activated Treg cells. Abatacept treatment resulted in marked decrease in the proportion of activated Tfh but slightly reduced Th17 and Treg cells. The proportion of Tfh cells was an independent and significant predictor of the response to abatacept therapy. CONCLUSION: Molecular targeted therapies induced different changes in different immune cell phenotypes. Among the phenotypes, Tfh cells seem a potential target for abatacept. Immunophenotypic analysis might be useful for prediction of the response to bDMARDs.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Nakayamada S, Kubo S, Yoshikawa M, et al. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Rheumatology (Oxford). 2018. PMID: 28371836. doi:10.1093/rheumatology/kex012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。